हॉजकिन लिम्फोमा
A chemotherapy response adapted management of an intense standard of care treatment regimen of classical Hodgkin Lymphoma in children, where the radiation therapy can be omitted based on the risk assessed through Positron Emission and Computerized Tomography imaging technique
हॉस्पिटल से संपर्क करें
रजिस्ट्री में इस hospital को trial के main contact के तौर पर दिखाया गया है। उनसे पूछिए कि कौन-कौन से hospital मरीज़ों को ले रहे हैं।
रजिस्ट्री समरी (तकनीकी)
Response-Adapted Management of Childhood Classical Hodgkin Lymphoma (cHL) and Early Response Assessment by Positron Emission and Computerized Tomography (PET-CT) to allow Omission of Radiotherapy in Indian Children Treated with a Standard of Care Intensified Chemotherapy Regimen
Sponsor: Dr Gaurav Narula Professor Medical OncologyPediatrics Unit Tata Memorial Hospital
CTRI, India के trial registry पर CTRI/2020/08/027495
Source: Clinical Trials Registry – India (CTRI), WHO ICTRP के ज़रिए, 12 Oct 2026 का data
Registry पर आखिरी बार 30 Mar 2026 को update किया गया · हमने 5 Nov 2026 को पढ़ा